• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cardinal Health expands home care business with two tuck-in acquisitions

    7/20/26 4:45:00 PM ET
    $CAH
    $AHCO
    Other Pharmaceuticals
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $CAH alert in real time by email

    DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy.

    Cardinal Health Logo

    Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments.

    "These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, Cardinal Health. "As a natural extension of our at-Home Solutions growth strategy, they expand our enterprise-wide depth and breadth across important therapeutic categories like diabetes management and urology, further strengthening our leadership in a highly dynamic industry."

    Both agreements enhance the framework established by Cardinal Health's most recent acquisition of Advanced Diabetes Supply (ADS). The company recently highlighted the progress of its at-Home Solutions business one year after its acquisition of ADS, including integration achievements that were realized ahead of plan. Since closing the original ADS transaction, the team successfully migrated all ADS volume onto the at-Home Solutions efficient and technology-enabled distribution network, onboarded nearly 500,000 new customers, and launched ContinuCare Pathway, a unique pharmacy-to-supplier digital referral pathway program.

    "Our significant operational achievements in FY26 position us to continue building the country's leading platform to deliver simplified, innovative and high-quality care in the home, both organically and through acquisition," said Rob Schlissberg, President of Cardinal Health at-Home Solutions.

    Layering these transactions on top of previous investments in the at-Home Solutions business also expands the company's ability to deliver high-quality service at scale. 

    AdaptHealth's Diabetes Health business, which serves more than 225,000 people annually, operates primarily as a centralized, mail-order, direct-to-patient model that delivers supplies like continuous glucose monitors to support the ongoing management of diabetes.

    Strive Medical serves more than 20,000 people annually as one of the nation's leading independent home medical supply providers specializing in urology, wound care, ostomy, and incontinence supplies, expanding Cardinal Health's enterprise-wide capabilities in this critical therapeutic area.  

    These transactions are subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals, and are expected to be accretive to non-GAAP earnings per share in the first 12 months following close.  

    Advisors

    J.P. Morgan Securities LLC served as financial advisor to Cardinal Health on both acquisitions. Skadden, Arps, Slate, Meagher & Flom LLP and DLA Piper served as legal advisors to Cardinal Health on the acquisition of AdaptHealth's diabetes business. BakerHostetler LLP and DLA Piper LLP served as legal advisors to Cardinal Health on the acquisition of Strive Medical.

    About Cardinal Health  

    Cardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; and a provider of performance and data solutions. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.

    About AdaptHealth

    AdaptHealth Corp. is a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies, and related services. Through its network of full-service medical equipment providers, AdaptHealth delivers tailored products and services designed to help patients manage chronic conditions and live independently in their homes. It serves beneficiaries of Medicare, Medicaid, and commercial insurance plans and reaches millions of patients annually.

    About Strive Medical LLC

    Strive Medical, an NMS Capital portfolio company, is a leading national durable medical equipment (DME) provider specializing in urology, incontinence, and wound care supplies delivered directly to patients. As an Accreditation Commission for Health Care (ACHC) accredited organization, Strive Medical manages the full insurance billing process – including Medicare, Medicaid, and over 5,000 private insurance plans – making access to essential supplies seamless for patients and referring providers alike. For more information, visit strivemedical.com

    Contacts

    Media: Cari Wildasinn, Cari.Wildasinn@cardinalhealth.com and (614) 757-8287

    Investors: David Frost, David.Frost@cardinalhealth.com and (614) 553-4460

    Cautions Concerning Forward-Looking Statements

    This news release contains forward-looking statements addressing expectations, prospects, estimates and other matters that are dependent upon future events or developments. These statements may be identified by words such as "expect," "anticipate," "intend," "plan," "believe," "will," "should," "could," "would," "project," "continue," "likely," and similar expressions, and include statements reflecting future results or guidance, statements of outlook, and various accruals and estimates. These matters are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. These risks and uncertainties include risks associated with the planned acquisitions addressed in this release, including the risk that we may not receive required regulatory approval or otherwise fail to complete one or both of the acquisitions and the risk that we may fail to realize the anticipated strategic and financial benefits of the acquisitions. Cardinal Health is subject to additional risks and uncertainties described in Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports. This news release reflects management's views as of July 20, 2026. Except to the extent required by applicable law, Cardinal Health undertakes no obligation to update or revise any forward-looking statement. Forward-looking statements are aspirational and not guarantees or promises that goals, targets or projections will be met, and no assurance can be given that any expectation, initiative or plan in this news release can or will be achieved or completed.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-expands-home-care-business-with-two-tuck-in-acquisitions-302829980.html

    SOURCE Cardinal Health

    Get the next $CAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAH
    $AHCO

    CompanyDatePrice TargetRatingAnalyst
    Cardinal Health Inc.
    $CAH
    4/28/2026Outperform
    William Blair
    Cardinal Health Inc.
    $CAH
    1/9/2026Neutral → Buy
    Citigroup
    Cardinal Health Inc.
    $CAH
    12/9/2025$243.00Overweight
    Barclays
    Cardinal Health Inc.
    $CAH
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    Cardinal Health Inc.
    $CAH
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    Cardinal Health Inc.
    $CAH
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    Cardinal Health Inc.
    $CAH
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    Cardinal Health Inc.
    $CAH
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $CAH
    $AHCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Commercial Officer Schuster Iii Russell E. sold $117,711 worth of shares (11,275 units at $10.44) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 125,263 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    7/6/26 4:01:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Williams David Solomon Iii was granted 18,999 shares, increasing direct ownership by 42% to 64,044 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/26/26 4:20:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Weaver Susan T was granted 18,999 shares, increasing direct ownership by 89% to 40,345 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    6/26/26 4:17:17 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $CAH
    $AHCO
    SEC Filings

    View All

    AdaptHealth Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    7/20/26 4:35:23 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    AdaptHealth Corp. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    7/7/26 4:45:49 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form 8-K filed by AdaptHealth Corp.

    8-K - AdaptHealth Corp. (0001725255) (Filer)

    7/2/26 4:01:45 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $CAH
    $AHCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Cashin Richard M Jr bought $19,912,148 worth of shares (2,046,691 units at $9.73) (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    3/12/26 9:11:41 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Director Wolf Dale B bought $71,680 worth of shares (8,000 units at $8.96), increasing direct ownership by 8% to 104,235 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    3/3/26 6:41:28 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    CLO and General Counsel Rew Richard W. Ii bought $44,550 worth of shares (5,000 units at $8.91), increasing direct ownership by 5% to 107,097 units (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    2/27/26 4:01:18 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $CAH
    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Cardinal Health

    William Blair initiated coverage of Cardinal Health with a rating of Outperform

    4/28/26 7:43:38 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health upgraded by Citigroup

    Citigroup upgraded Cardinal Health from Neutral to Buy

    1/9/26 8:24:26 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Barclays initiated coverage on Cardinal Health with a new price target

    Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00

    12/9/25 8:43:24 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    $AHCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health expands home care business with two tuck-in acquisitions

    DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments."These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, C

    7/20/26 4:45:00 PM ET
    $CAH
    $AHCO
    Other Pharmaceuticals
    Health Care
    Medical/Nursing Services

    AdaptHealth Corp. Enters into Definitive Agreement to Divest Diabetes Health Business to Cardinal Health

    Continues the Company's multi-year effort to focus its portfolio on its core sleep, respiratory, and supporting home medical equipment businesses Sharpens strategic focus on businesses where the Company crosses the threshold of the home to deliver clinical value to patients Increases capital flexibility for reinvestment in core businesses and debt reduction, accelerating AdaptHealth's deleveraging trajectory and strengthening its balance sheet Improves AdaptHealth's expected revenue growth profile and adjusted EBITDA margins on a go-forward basis Positions Diabetes Health with an owner whose scale and operational capabilities are matched to the demands of direct-to-patient dist

    7/20/26 4:30:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer

    Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platformsNASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations, today announced the appointment of Gary M. Kirsh, M.D. as Chief Executive Officer, effective immediately. Dr. Kirsh has served on CVL's Board of Directors since November 2025 and brings more than three decades of experience building and leading large, physician-led specialty platforms. Dr. Kirsh is the co-founder and former Chief Executive Officer of Solaris Health, which he built into the largest urology mana

    7/14/26 5:15:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    $AHCO
    Financials

    Live finance-specific insights

    View All

    AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its second quarter 2026 financial results before the opening of the financial markets on Tuesday, August 4, 2026. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors. Interested parties may participate in the call by dialing: (800) 274-8461 (Domestic) or (203) 518-9814 (International) When prompted, reference Conference ID: AHCO2Q26 Webcast registration: Click Here Followin

    7/14/26 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an opera

    5/5/26 4:40:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    AdaptHealth Corp. Announces First Quarter 2026 Results

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2026. First Quarter Business Highlights Completed the largest de novo expansion in the history of the home medical equipment industry, meeting an aggressive go live schedule to become the exclusive provider to the more than 10 million members of our new strategic partner. The acceleration of the transition came with $12 million of elevated labor expense, of which the majority was variable and is ex

    5/5/26 7:00:00 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $CAH
    $AHCO
    Leadership Updates

    Live Leadership Updates

    View All

    Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer

    Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platformsNASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations, today announced the appointment of Gary M. Kirsh, M.D. as Chief Executive Officer, effective immediately. Dr. Kirsh has served on CVL's Board of Directors since November 2025 and brings more than three decades of experience building and leading large, physician-led specialty platforms. Dr. Kirsh is the co-founder and former Chief Executive Officer of Solaris Health, which he built into the largest urology mana

    7/14/26 5:15:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

    DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately. Mr. Kenny has served on the Board since 2007 and as Chairman since 2018. During his tenure on the Board, Mr. Kenny supported the Company through periods of significant transformation, including strategic portfolio evolution and operational improvement initiatives."On behalf of the Board and our management team, we are d

    3/23/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    After Major Oncology Conference, All Eyes Turn to Industry Innovation

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

    6/12/25 9:00:00 AM ET
    $CAH
    $CTOR
    $CTXR
    Other Pharmaceuticals
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $CAH
    $AHCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/14/24 9:03:31 AM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G filed by AdaptHealth Corp.

    SC 13G - AdaptHealth Corp. (0001725255) (Subject)

    11/13/24 9:30:46 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by AdaptHealth Corp.

    SC 13G/A - AdaptHealth Corp. (0001725255) (Subject)

    11/12/24 1:30:20 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care